Half of US Hispanic consumers are seeking information on OTC products, say experts on Hispanic marketing during a CHPA webinar on the Hispanic path to purchase. Thirty-six percent of Hispanics glean data on OTCs from TV ads, compared to 19% of non-Hispanics.
Hispanic consumers in the US are more receptive to OTC drug advertising and are less price sensitive, factors that make the demographic of 58m a rich target for drug marketers, advertising consultants suggest.
“This consumer is hungry for information, proactive about their health, but feel they need help,” said Carlos Gutierrez, vice president,...
Developments in India and Pakistan are designed to standardize how drug companies disclose their expenses associated with health care professionals.
AbbVie’s migraine ad overstates the drug’s benefit, a problem that is amplified by using a celebrity, the agency says.
The lung cancer drug Krazati from Bristol Myers Squibb’s Mirati Therapeutics drew an FDA ad/promo untitled letter, highlighting the agency's trend of pursuing false or misleading efficacy claims, particularly when data comes from outside approved labeling.
The UK and EU pharma industry associations have defended their respective codes of practice despite alarming study results. Meanwhile, a consultation on proposals to revise the UK code received over 3,500 comments.
Joint clinical assessment reports must be descriptive rather than reach definitive conclusions, and must not interfere with national decision making processes, according to new EU guidance.
Developments in India and Pakistan are designed to standardize how drug companies disclose their expenses associated with health care professionals.
The agency’s plan for advanced manufacturing seeks more harmonization, while also seeking to codify internal practices with guidance and training.
